Icon Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.69M | Sell |
3,349
-2,316
| -41% | -$1.17M | 0.19% | 91 |
|
|
2023
Q2 | $2.96M | Sell |
5,665
-231
| -4% | -$121K | 0.31% | 65 |
|
|
2023
Q1 | $3.4M | Buy |
+5,896
| New | +$3.4M | 0.37% | 64 |
|
|
2022
Q2 | $325K | Sell |
599
-80
| -12% | -$43.4K | 0.04% | 239 |
|
|
2022
Q1 | $401K | Sell |
679
-46
| -6% | -$27.2K | 0.04% | 233 |
|
|
2021
Q4 | $484K | Buy |
725
+6
| +0.8% | +$4.01K | 0.05% | 215 |
|
|
2021
Q3 | $411K | Sell |
719
-3
| -0.4% | -$1.72K | 0.04% | 240 |
|
|
2021
Q2 | $364K | Buy |
722
+55
| +8% | +$27.7K | 0.04% | 270 |
|
|
2021
Q1 | $304K | Buy |
667
+36
| +6% | +$16.4K | 0.04% | 266 |
|
|
2020
Q4 | $294K | Sell |
631
-109
| -15% | -$50.8K | 0.05% | 232 |
|
|
2020
Q3 | $327K | Sell |
740
-885
| -54% | -$391K | 0.06% | 184 |
|
|
2020
Q2 | $589K | Buy |
1,625
+852
| +110% | +$309K | 0.14% | 112 |
|
|
2020
Q1 | $219K | Sell |
773
-64
| -8% | -$18.1K | 0.09% | 135 |
|
|
2019
Q4 | $272K | Buy |
+837
| New | +$272K | 0.09% | 135 |
|
|
2019
Q2 | – | Sell |
-417
| Closed | -$114K | – | 712 |
|
|
2019
Q1 | $114K | Buy |
+417
| New | +$114K | 0.04% | 213 |
|
|
2018
Q4 | – | Sell |
-417
| Closed | -$102K | – | 251 |
|
|
2018
Q3 | $102K | Sell |
417
-50
| -11% | -$12.2K | 0.04% | 268 |
|
|
2018
Q2 | $97K | Buy |
+467
| New | +$97K | 0.04% | 243 |
|
|
2018
Q1 | – | Sell |
-551
| Closed | -$105K | – | 683 |
|
|
2017
Q4 | $105K | Buy |
+551
| New | +$105K | 0.05% | 267 |
|